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from a single gene. All of these changes in mRNA struc-
ture can be regulated in diverse ways, depending on
sexual genotype, cellular differentiation, or the activa-
tion of particular cell signaling pathways.
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of the encoded protein is similarly diverse (Lopez, 1998;Los Angeles, California 90095
Smith and Valcarcel, 2000). In some transcripts, whole
functional domains can be added or subtracted from
the protein coding sequence. In other systems, the intro-
The human genome sequence can be thought of as a duction of an early stop codon can result in a truncated
picture of the human organism. However, like an impres- protein or an unstable mRNA (Morrison et al., 1997).
sionist painting, the genome is a very large canvas Alternative splicing is also commonly used to control the
whose details become fuzzy when you look closely. A inclusion of particular short peptide sequences within a
fully detailed image of a complex organism requires longer protein. These optional peptide sequence cas-
knowledge of all of the proteins and RNAs produced settes range from one to hundreds of amino acids in
from its genome. This is the impetus for proteomics, the length, and have very specific effects on the activity of
study of the complete protein sets of organisms. Due a protein product. Changes in splicing have been shown
to the production of multiple mRNAs through alternative to determine the ligand binding of growth factor recep-
RNA processing pathways, human proteins often come tors and cell adhesion molecules, and to alter the activa-
in multiple variant forms. Because of our ignorance of tion domains of transcription factors (Lopez, 1998; Smith
the rules governing splice site choice, today’s tools for and Valcarcel, 2000). In other systems, the splicing pat-
analyzing genomic sequence provide a picture of these tern of an mRNA determines the subcellular localization
gene products that is highly indistinct. Our ability to of the encoded protein, the phosphorylation of the pro-
define the product RNA and protein structures encoded tein by kinases, or the binding of an enzyme by its allo-
within genomic sequence will need to improve greatly steric effector. Determining how these sometimes subtle
before a complete genome sequence can tell us the fine changes in sequence affect protein function is a crucial
details of an organism’s protein constitution. question in many different problems in developmental
Splicing Analysis as a Fine Brush on the Genome and cell biology including control of apoptosis (Jiang
Alternative splicing is seen in nearly all metazoan organ- and Wu, 1999), tumor progression (Herrlich et al., 1993),
isms as a means for producing functionally diverse poly- neuronal connectivity (Schmucker et al., 2000), and the
peptides from a single gene (Lopez, 1998). It is especially tuning of cell excitation and cell contraction.
common in vertebrates; alignment of EST sequences A recent discovery in Drosophila is both a fascinating
and mapping the resulting mRNA families to the human example of the subtle structural changes that can be
genome provided a minimum estimate that 35% of hu- made in a protein and a remarkable demonstration of
man genes show variably spliced products (Croft et al., the number of proteins that can be produced from a
2000 and references therein). However, since these single gene using alternative splicing. Drosophila DSCAM
ESTs derive from a limited number of tissues or develop- protein was cloned as an axon guidance receptor re-
mental states, and cover only a limited portion of each sponsible for directing growth cones to their proper tar-
mRNA, the true percentage is likely much higher. More- get in Bolwig’s nerve of the fly (Schmucker et al., 2000).
over, it is common to see genes with a dozen or more The isolated DSCAM cDNAs showed several positions
different transcripts. There are also remarkable exam- of heterogeneity attributable to alternative splicing.
ples of hundreds and even thousands of functionally However, comparison of these cDNAs to the DSCAM
genomic sequence held a surprise. In addition to thedivergent mRNAs and proteins being produced from a
exons encoding the isolated cDNAs, dozens of differentsingle gene. In the human genome, such protein-rich
homologous exons were also present in what would begenes include the Neurexins, n-Cadherins, calcium-acti-
the DSCAM primary transcript. Exons 4, 6, 9, and 17 arevated potassium channels, and others. Thus, the esti-
each encoded by an array of potential alternative exonsmated 35,000–80,000 genes in the human genome could
(Figure 1). These exons are used in a mutually exclusiveeasily produce several hundred thousand different pro-
manner, where there are 12 alternatives for exon 4, 48teins, and possibly more.
alternatives for exon 6, 33 alternatives for exon 9, andVariation in mRNA structure takes many different
2 alternatives for exon 17. If all combinations of theseforms (Lopez, 1998; Smith and Valcarcel, 2000). Exons
exons were used, the single DSCAM gene would pro-can be spliced into the mRNA or skipped. Introns that
duce 38,016 different DSCAM proteins! Cloning and se-are normally excised can be retained in the mRNA. The
quencing 50 different random cDNAs identified 49 differ-positions of either 59 or 39 splice sites can shift to make
ent combinations of exons 4, 6, and 9. Thus, even if notexons longer or shorter. In addition to these changes in
all exon combinations are allowed, it is clear that this onesplicing, alterations in transcriptional start site or poly-
gene produces many thousands of protein products.adenylation site also allow production of multiple mRNAs
Although it is not yet known how they affect function,
the changes in DSCAM protein structure brought about
by these changes in splicing are interesting. Exons 4* E-mail: dougb@microbio.lifesci.ucla.edu
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Figure 1. 38,016 Shades of DSCAM
The DSCAM gene (top) is 61.2 kb long and
after transcription and splicing produces a
7.8 kb, 24 exon mRNA (middle). Exons 4, 6,
9, and 17 are encoded as arrays of mutually
exclusive alternative exons. Each mRNA will
contain one of 12 possible alternatives for
exon 4 (in red), one of 48 for exon 6 (blue),
one of 33 for exon 9 (green) and one of 2 for
exon 17 (yellow). In the final protein product
(bottom), exon 4 encodes the amino-terminal
half of Ig domain 2. Exon 6 encodes the same
portion of Ig domain 3, exon 9 encodes all of Ig domain 7, and 17 encodes the transmembrane domain. If all possible combinations of single
exons 4, 6, 9, and 17 are used, the DSCAM gene produces 38,016 different mRNAs and proteins.
and 6 encode the N-terminal half of the 2nd and 3rd immu- The choice of splice sites is thought to be directed
by proteins that bind to special non–splice site RNAnoglobulin domains within the extracellular portion of
the receptor. The multiple forms of exon 9 each encode elements and then enhance or repress spliceosome as-
sembly nearby (Figure 2) (Lopez, 1998; Smith and Valcar-an entire Ig domain 7. Each exon 17 encodes an alternate
transmembrane domain. A similar splicing change in an cel, 2000). Splicing regulators include members of the
SR family of proteins as well as factors generally classedIg domain of the FGF Receptor 2 mRNA determines
which of several growth factors the receptor will respond as hnRNP proteins. The best understood are the SR pro-
teins which, among other activities, can bind to exonicto. Thus, although similar in overall protein structure, the
different DSCAM receptors are likely to have important splicing enhancer elements and stimulate spliceosome
assembly at adjacent splice sites, possibly through di-differences in activity. The implications of this diversity
in axon guidance receptors for neuronal development rect interactions with U2AF and the U1 snRNP. Along a
given pre-mRNA, a great many different SR and hnRNPhave been discussed elsewhere (Schmucker et al.,
2000), but the gene itself provides a spectacular indica- proteins will bind to many short sequence elements pro-
ducing a complex RNP structure (Krecic and Swanson,tion of how much protein diversity can be generated by
alternative splicing. The Drosophila genome contains 1999; Lopez, 1998; Smith and Valcarcel, 2000). Most
systems of alternative splicing appear to be highly com-approximately 13,600 identified genes (Adams et al.,
2000), whereas this single gene can produce nearly three binatorial, with multiple positive and negative factors
and elements influencing the final level of a spliced tran-times that number of proteins. It has been a puzzle that
an organism as complex as a fly would need so few script. This complexity makes the molecular character-
ization of splicing regulation challenging. So far, only agenes to describe all of its functions. It seems clear that
due to alternative splicing the gene number is not an few systems of regulated splice site choice have been
genetically or biochemically dissected, and most regula-estimate of the protein complexity of the organism.
However fascinating this diversity of products, we are tory proteins and sequence elements are not yet iden-
tified.at a loss to explain what might control DSCAM splicing,
for the mechanisms of alternative splicing regulation are The general lack of understanding of how cells choose
splice sites, and how they change particular choices,poorly understood. During the course of the splicing
reaction, each intron in a pre-mRNA is assembled into makes it difficult to identify exons and predict splicing
patterns within genomic sequence. Functional splicea spliceosome complex, where the splice sites at the
intron ends are brought together and the cleavage and sites do not always match the consensus sequences
well. Conversely, there are many cryptic sites in theligation reactions are catalyzed (Staley and Guthrie,
1998). The spliceosome is a large particle made of a set genome that match the consensus but are not normally
recognized by the splicing apparatus. The sequenceof 5 small nuclear ribonucleoproteins, the U1, U2, U4,
U5, and U6 snRNPs, as well as a number of important surrounding a splice site, as well as its match to the
consensus, strongly affects its recognition. Introns canauxiliary proteins. The splice sites at the intron/exon
junctions adhere to particular consensus sequences. be very long, whereas exons are generally short, and
one feature affecting the recognition of a splice site isEarly in spliceosome assembly, the 59 splice site at the
59 end of the intron is bound by the U1 snRNP. One of the presence of the opposite site across the exon. Thus,
splicing at a 39 splice site in one intron can be stimulatedthe non-snRNP proteins, the U2 Auxiliary Factor (U2AF),
binds to the polypyrimidine tract of the 39 splice site by the 59 splice site across the exon in the downstream
intron. This has given rise to the concept of exon defini-and stimulates U2 snRNP binding upstream (Figure 2).
At this point in the assembly of the spliceosome, the tion, where splice sites are thought to be recognized as
one end of an exon unit, rather than as individual sitessplice sites have apparently been chosen and paired to
define the excised intron. Later steps in the assembly separated by a long intron (Berget, 1995). However, even
by looking for splice sites in exon pairs, it is often difficultbring in the other snRNPs and rearrange their structure
to put the splice sites into the active center of the to distinguish real from cryptic sites; it is clear that se-
quences outside the splice sites themselves stronglyspliceosome and allow for catalysis. The alteration of
splice site choice is an alteration in the assembly of the affect their use. Current gene finding programs identify
exons based on multiple properties such as coding ca-early spliceosome complex that changes the end points
of an excised intron and hence the structure of the final pacity combined with matches to the consensus splice
sites (Burge and Karlin, 1997; Haussler, 1998 and refer-mRNA.
Minireview
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Figure 2. Spliceosome Assembly on Regu-
lated and Unregulated Splice Sites
A pre-mRNA (top) is spliced according to
where the spliceosome assembles and de-
fines its introns and exons. The U1 snRNP
binds to 59 splice sites. The U2 snRNP and
auxiliary proteins, including U2AF and SF1,
bind to the branchpoint and the 39 splice site.
The binding of these initial components and
the assembly of the early spliceosome com-
plexes is thought to define the intron to be
excised. In later steps, the full spliceosome
forms and catalyzes the cleavage and ligation
reactions at the earlier defined splice sites.
The spliceosome can assemble between
exon 1 and exon 3 to excise a single large
intron and form mRNA 1. Alternatively, two
spliceosomes can excise two smaller introns,
thus including a new exon in the mRNA
(mRNA 2). These outcomes can be determined by negative regulatory proteins (red) that either prevent U1 or U2 binding at particular sites
(as shown), or block spliceosome assembly after U1 or U2 binding. Regulatory proteins can also act positively (blue) to enhance spliceosome
assembly at sites that are otherwise recognized poorly. Most systems of alternative splicing seem to be controlled by multiple regulatory
proteins that may exert both positive and negative control. Splicing patterns can also be affected by other factors, including RNA secondary
structure and transcription rate.
ences therein). Exons containing clear open reading dance mRNAs and will miss potentially important prod-
ucts. However, they will provide an initial referenceframes are most easily recognized, but at the ends of
these exons the splice sites can be difficult to predict splicing pattern for many genes. Such a large-scale
identification of constitutive and regulated exons shouldwhen there are multiple consensus sequence matches
in the region. Exon prediction becomes even less suc- also give us a great deal of information on the features
and sequences that distinguish actual exons from thecessful with short exons. Microexons, encoding from
one to a dozen or so amino acids, are common, but are cryptic splice sites not normally recognized by the splic-
ing apparatus. In addition to improving algorithms fordifficult to identify in genomic DNA because of their lack
of coding capacity. Until we know more about how cells predicting spliced segments within genomic sequence,
this information will give insight into the mechanismsrecognize splice sites, it will be difficult to write software
to predict the exonic structure of genes. This is a major of alternative splicing and help experimentalists make
sense of their complex biochemical systems.limitation in our ability to annotate the genome.
The Long Bioinformatics View of Splicing Much more difficult than identifying exons correctly will
be predicting splicing regulatory patterns from genomicWith a painting, although the close view may be indis-
tinct, the view of the whole can resolve itself into a sequence. This issue can be seen in the DSCAM gene
sequence where the alternative exons were relativelydiscernable picture. Similarly, the global view of the ge-
nome will provide a unique vantage for understanding easy to identify through protein homology (Schmucker
et al., 2000). However, the same sequence gives nosplicing. Since only a few systems of alternative splicing
are likely to be analyzed in biochemical detail at least clues about how these exons are regulated or which
exons might be used in particular cells. Alternative exonsin the near term, bioinformatics approaches will be im-
portant in predicting alternative splicing patterns from have binding sites for multiple regulatory proteins that
often show only subtle variation between tissues, andgenomic sequence. Simple sequence comparisons are
a first step. Microexons and intronic splicing regulatory the sequence elements that control exons of very differ-
ent tissue specificity can look similar (Smith and Valcar-regions are often much more highly conserved between
species than other intron sequence (see for example cel, 2000). Thus, even where we identify important regu-
latory sequences and proteins for an exon, it will beThackeray and Ganetzky, 1995). Comparison of the
mouse and human or the D. melanogaster and D. virilis difficult to predict the precise tissues or conditions that
lead to splicing activation or repression.genomes will yield a great deal of information on exon
location and on splicing regulatory sequences. The combinatorial nature of splicing regulation is simi-
lar to the control of transcription through promoter andWork is also underway to align the EST and cDNA
databases with genome sequences (Kent and Zahler, enhancer elements and poses similar problems (Smith
and Valcarcel, 2000). Many of the whole genome experi-2000; Wolfsberg and Landsman, 1997). Although this
alignment approach again has difficulties in identifying mental approaches already being applied to transcrip-
tional regulation can be informative for splicing as wellshort exons and exon termini correctly (Florea et al.,
1998), it can in principle identify all the splicing occurring (Young, 2000). Microarray technologies that allow the
simultaneous assessment of the splicing of many exonswithin the sequenced portion of existing cDNAs. At the
moment, this is only a small portion of the splicing events within an RNA sample should prove particularly helpful.
Unlike the detection of RNAs to measure whole tran-in the genome, but projects to generate large databases
of full-length cDNA sequences will greatly improve its script levels, these alternative splicing detector arrays
will monitor the inclusion of particular exons in differentcoverage (Strausberg et al., 1999; Rubin et al., 2000).
These efforts are unlikely to identify many low abun- populations of mRNAs. In one strategy, a position on
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Rubin, G.M., Hong, L., Brokstein, P., Evans-Holm, M., Frise, E., Sta-the array would contain an oligonucleotide complemen-
pleton, M., and Harvey, D.A. (2000). Science 287, 2222–2224.tary to either a differentially included exon or to the exon/
Schmucker, D., Clemens, J., Shu, J., Worby, C., Xiao, J., Muda, M.,exon junction generated when this exon is skipped. The
Dixon, J., and Zipursky, L. (2000). Cell 101, 671–684.relative hybridization of a sample to these two se-
Smith, C.W., and Valcarcel, J. (2000). Trends Biochem. Sci. 25,quences will give a measure of the relative inclusion of
349–404.
the exon. One limitation of this approach is that it does
Staley, J.P., and Guthrie, C. (1998). Cell 92, 315–326.not give information correlating the exons within a single
Strausberg, R.L., Feingold, E.A., Klausner, R.D., and Collins, F.S.mRNA. For example, in the DSCAM gene, one would
(1999). Science 286, 455–457.
identify the alternatives for exons 4 and 6 that were
Thackeray, J.R., and Ganetzky, B. (1995). Genetics 141, 203–214.
present in a total mRNA sample, but which particular
Wolfsberg, T.G., and Landsman, D. (1997). Nucleic Acids Res. 25,exons 4 and 6 were used together in the same mRNA
1626–1632.
molecule would not be discernable. Most importantly,
Young, R. (2000). Cell 102, 9–15.
however, such a technology permits one to examine the
coordinate regulation of large groups of exons de-
pending on development, cell type, or extracellular stim-
ulus. This system-wide data about exon use may lead
to the identification of sequence features that determine
particular patterns of expression.
The presence or absence of particular exons in an
mRNA can also be correlated with data on the expres-
sion patterns of potential splicing regulators, such as
SR proteins or hnRNPs. Combined with conditional
knockouts of these regulators, we can ask precise ques-
tions about what combinations of regulatory proteins are
needed for particular exons. Although it is recognized as
a significant problem in the understanding transcrip-
tional regulation, the question of combinatorial control
of splicing is only beginning to be addressed. Neverthe-
less, this understanding of how exons are regulated
on a system-wide scale will ultimately be essential in
interpreting genome sequence and predicting how and
when certain proteins are produced from it.
Only a global view of splicing regulation combined
with a detailed understanding of its mechanisms will
allow us to paint a picture of an organism’s total comple-
ment of proteins and of how this complement changes
with development and the environment. Working toward
this goal should keep bioinformatics researchers and
molecular biologists busy for some time into the post-
genome era.
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